Dr. Lewis and team’s Rapid Infection Diagnostics (RID) Inc. has launched its Hopper™ metabolomics-based platform for identifying bacteria and testing their susceptibility to antibiotics. The UCeed Health Opportunity Fund will provide key commercialization support for this life-saving innovation. Click here to read the article by UCalgary News’ Brennan Black.
Lewis Research Group awarded UCeed support